A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

Clinical trial NCT00319917 · COMPLETED

Trial details

NCT number: NCT00319917
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-04-01
Primary completion: 2008-10-01
Enrollment: 123

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.